The recent FDA roundtable on hormone replacement therapy (HRT) marks a pivotal moment in the discourse surrounding women's health, particularly in the context of menopause and perimenopause. This episode delves into the implications of this groundbreaking event, emphasizing that a reevaluation of the historical skepticism surrounding hormone therapy is both necessary and timely. We discuss the detrimental effects stemming from the mass discontinuation of HRT following the 2002 Women’s Health Initiative, which inadvertently led to increased psychological distress and physical health issues among women. Furthermore, we highlight the importance of comprehensive education for healthcare providers, noting that a mere 20% of OB-GYN residencies incorporate menopause training, thereby contributing to widespread misinformation and inadequate care. As we navigate these complexities, we advocate for a holistic and integrative approach to menopause management, underscoring the need for updated clinical guidelines that reflect contemporary research and the diverse needs of women.

Links referenced in this episode:

• modernmeno.com